Loading company…
Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.
CELLERGY PHARMA has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $600,000 between 2024 and 2025. These are non-dilutive federal research grants, not equity financing. The company is based in WILMINGTON, Delaware.
No investors recorded yet for CELLERGY PHARMA.
Add an investorCELLERGY PHARMA has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for CELLERGY PHARMA.
Add diversity data